{
    "target": "Tyrosine-protein kinase ABL1",
    "paper_name": "AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL",
    "DOI": "10.1038/sj.bjc.6603170",
    "paper_id": "weisberg2006",
    "pockets": [
        {
            "pocket_id": "ATP binding site",
            "description": "The novel, selective BCRABL inhibitor, AMN107, was designed to fit into the ATP-binding site of the BCR-ABL protein with higher affinity than imatinib.",
            "amino_acids": [
                "Met318",
                "Thr315",
                "Glu286",
                "Asp381"
            ],
            "ligands": [
                "AMN107 (nilotinib)"
            ]
        }
    ]
}